Skip to Content

UK Edition. Click here for US version.



View full screen / Print PDF » Download PDF ⇩

PDF Transcript

Package leaflet: Information for the user

Risedronate Sodium 35mg film-coated tablets
Risedronate sodium

Read all of this leaflet carefully before you start taking this medicine
because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as yours.
- If you get any side effects talk to your doctor or pharmacist or nurse.
This includes any possible side effects not listed in this leaflet. See
section 4.
What is in this leaflet:
1. What Risedronate is and what it is used for
2. What you need to know before you take Risedronate
3. How to take Risedronate
4. Possible side effects
5. How to store Risedronate
6. Contents of the pack and other information

1. What Risedronate is and what it is used for
What Risedronate is
Risedronate belongs to a group of non-hormonal medicines called
bisphosphonates which are used to treat bone diseases. It works directly
on your bones to make them stronger and therefore less likely to break.
Bone is a living tissue. Old bone is constantly removed from your
skeleton and replaced with new bone.
Postmenopausal osteoporosis is a condition occurring in women after
the menopause where the bones become weaker, more fragile and more
likely to break after a fall or strain.
Osteoporosis can also occur in men due to a number of causes including
ageing and/or a low level of the male hormone, testosterone.
The spine, hip and wrist are the most likely bones to break, although this
can happen to any bone in your body. Osteoporosis-related fractures can
also cause back pain, height loss and a curved back. Many patients with
osteoporosis have no symptoms and you may not even have known that
you had it.
What Risedronate is used for
The treatment of osteoporosis
• in postmenopausal women, even if osteoporosis is severe. It reduces
the risk of spinal and hip fractures.
• in men.

2. What you need to know before you take Risedronate
Do not take Risedronate
- if you are allergic to risedronate sodium or any of the other ingredients
of this medicine (listed in section 6).
- if your doctor has told you that you have a condition called
hypocalcaemia (a low blood calcium level).
- if you may be pregnant, are pregnant or are planning to become
- if you are breast-feeding.
- if you have severe kidney problems.
Warnings and precautions
• If you are unable to stay in an upright position (sitting or standing) for
at least 30 minutes.
• If you have abnormal bone and mineral metabolism (for example lack
of vitamin D, parathyroid hormone abnormalities, both leading to a
low blood calcium level).
• If you have had problems in the past with your oesophagus (the tube
that connects your mouth with your stomach). For instance you may
have had pain or difficulty in swallowing food or you have previously
been told that you have Barrett’s oesophagus (a condition associated
with changes in the cells that line the lower oesophagus).
• If you have been told by your doctor that you have an intolerance to
some sugars (such as lactose).
• If you have had or have pain, swelling or numbness of the jaw or a
“heavy jaw feeling” or loosening of a tooth.

• If you are under dental treatment or will undergo dental surgery, tell
your dentist that you are being treated with Risedronate.
Your doctor will advise you on what to do when taking Risedronate if you
have any of the above.
Children and adolescents
Risedronate sodium is not recommended for use in children below 18
due to insufficient data on safety and efficacy.
Other medicines and Risedronate
Medicines containing one of the following lessen the effect of Risedronate
if taken at the same time:
• calcium
• magnesium
• aluminium (for example some indigestion mixtures)
• iron
Take these medicines at least 30 minutes after taking Risedronate.
Tell your doctor or pharmacist if you are taking, have recently taken or
might take any other medicines.
Taking Risedronate with food and drink
It is very important that you do NOT take your Risedronate tablet with
food or drinks (other than plain water) so that it can work properly. In
particular do not take this medicine at the same time as dairy products
(such as milk) as they contain calcium (see section 2, “Other medicines
and Risedronate”).
Take food and drinks (other than plain water) at least 30 minutes after
your Risedronate tablet.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are
planning to have a baby, ask your doctor or pharmacist for advice before
taking this medicine.
Do NOT take Risedronate if you may be pregnant, are pregnant or are
planning to become pregnant (see section 2 “Do not take Risedronate”).
The potential risk associated with the use of risedronate sodium (active
substance in Risedronate) in pregnant women is unknown.
Do NOT take Risedronate if you are breast-feeding (see section 2
“Do not take Risedronate”).
Driving and using machines
Risedronate is not known to affect your ability to drive and use machines.
Risedronate contains lactose
If you have been told by your doctor that you have an intolerance to
some sugars, contact your doctor before taking this medicinal product
(see section 2, “Warnings and precautions”).

3. How to take Risedronate
Always take this medicine exactly as your doctor has told you. You
should check with your doctor or pharmacist if you are not sure.
Usual dose
Take ONE Risedronate (35mg risedronate sodium) once a week.
Choose one day of the week that best fits your schedule. Every week,
take the Risedronate tablet on your chosen day.
There are boxes/spaces on the carton. Please mark the day of the week
you have chosen to take your Risedronate tablet. Also write in the dates
you will take the tablet.
When to take your Risedronate tablet:
Take your Risedronate tablet at least 30 minutes before the first food,
drink (other than plain water) or other medicine of the day.
How to take your Risedronate tablet:
Take the tablet whilst you are in an upright position (you may sit or
stand) to avoid heartburn.
Swallow it with at least one glass (120 ml) of plain water.

Swallow it whole. Do not suck or chew the tablet.
Do not lie down for 30 minutes after taking the tablet.
Your doctor will tell you if you need calcium and vitamin supplements, if
you are not taking enough from your diet.
If you take more Risedronate than you should
If you or somebody else has accidentally taken more Risedronate tablets
than prescribed, drink one full glass of milk and seek medical attention.
If you forget to take Risedronate
If you have forgotten to take your tablet on chosen day, take it on the day
you remember.
Return to taking one tablet once a week on the day the tablet is
normally taken.
Do not take two tablets in one day to make up for the tablet you missed.
If you stop taking Risedronate
If you stop treatment you may begin to lose bone mass. Please talk to
your doctor before you consider stopping treatment.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not
everybody gets them.
Stop taking Risedronate and contact a doctor immediately if you
experience any of the following:
Symptoms of a severe allergic reaction such as;
• Swelling of the face, tongue or throat
• Difficulties in swallowing
• Hives and difficulties in breathing
Severe skin reactions that can include blistering of the skin.
Tell your doctor promptly if you experience the following side effects:
Eye inflammation, usually with pain, redness and light sensitivity.
Bone necrosis of the jaw (osteonecrosis) associated with delayed
healing and infection, often following tooth extraction (see section 2,
“Warnings and precautions”).
Symptoms from oesophagus such as pain when you swallow, difficulties
in swallowing, chest pain or new/worsened heartburn.
Very rare:
• Talk to your doctor if you have ear pain, discharge from the ear, and/
or an ear infection. These could be signs of bone damage in the ear.
However in clinical studies the other side effects that were
observed were usually mild and did not cause the patient to stop taking
their tablets.
Common side effects (affects 1 to 10 users in 100):
Indigestion, feeling sick, stomach ache, stomach cramps or discomfort,
constipation, feelings of fullness, bloating, diarrhoea.
Pain in your bones, muscles or joints.
Uncommon side effects (affects 1 to 10 users in 1,000):
Inflammation or ulcer of the oesophagus (the tube that connects your
mouth with your stomach) causing difficulty and pain in swallowing (see
also section 2, “Warnings and precautions”), inflammation of the stomach
and duodenum (bowel draining the stomach).
Inflammation of the coloured part of the eye (iris) (red painful eyes with a
possible change in vision).
Rare side effects (affects 1 to 10 users in 10,000):
Inflammation of the tongue (red swollen, possibly painful), narrowing of
the oesophagus (the tube that connects your mouth with your stomach).
Abnormal liver tests have been reported. These can only be diagnosed
from a blood test.
Unusual fracture of the thigh bone particularly in patients on long-term
treatment for osteoporosis may occur rarely. Contact your doctor if you
experience pain, weakness or discomfort in your thigh, hip or groin as
this may be an early indication of a possible fracture of the thigh bone.
During post-marketing experience, the following have been reported
(unknown frequency);
Allergic reactions of the skin such as urticaria (hives), skin rash, swelling
of the face, lips, tongue and/or neck, difficulty in swallowing or breathing.
Severe skin reactions including vesiculation (blistering) under the skin;
inflammation of small blood vessels, characterised by palpable red spots
on the skin (leukocytoclastic vasculitis); a serious illness called Stevens
Johnson syndrome (SJS) with blistering of the skin, mouth, eyes and

other moist body surfaces (genitals); a severe illness called toxic
epidermal necrolysis (TEN) which causes a red rash over many parts of
the body and/or loss of the outer layer of skin. Hair loss. Allergic reactions
(hypersensitivity). Serious liver disorders, mainly if you are treated with
other medicinal products known to cause liver problems. Inflammation of
the eye which causes pain and redness.
Rarely, at the beginning of treatment, a patient’s blood calcium and
phosphate levels may fall.
These changes are usually small and cause no symptoms.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist or nurse.
This includes any possible side effects not listed in this leaflet. You can
also report side effects directly via the Yellow Card Scheme (website: By reporting side effects you can help
provide more information on the safety of this medicine.

5. How to store Risedronate

Keep out of the sight and reach of children.
This medicinal product does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the
carton. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste.
Ask your pharmacist how to throw away medicines you no longer use.
These measures will help to protect the environment.

6. Contents of the pack and other information
What Risedronate contains
- The active substance is Risedronate sodium. Each tablet contains
35mg risedronate sodium, equivalent to 32.5mg risedronic acid.
- The other ingredients are:
Tablet core: Starch, pregelatinised (maize); Cellulose, microcrystalline;
Crospovidone; Magnesium stearate.
Film coating: Hypromellose, Lactose monohydrate, Titanium dioxide
(E171), Macrogol 4000.
What Risedronate looks like and contents of the pack
Risedronate are white round biconvex film-coated tablets with diameter
of 11.2mm, 5.0mm in thickness and embossed with ‘35’ on one side.
They are supplied in blister packs containing 1, 2, 4, 10, 12, 16 and
24 tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder & Manufacturer
Pharmathen SA
6 Dervenakion str,
15351 Pallini
Aspire Pharma Limited
Bellamy House
Winton Road
GU32 3HA
United Kingdom
This leaflet was last revised in


Artwork for:
Aspire Pharma Limited
Product name:
Risedronate 35mg
PL/PA no: PL17277/0239
Type: Leaflet
Artwork dimensions: 250mm x 170mm
Profile supplied: Yes
Date of first artwork: 7 June 2010
Reason for request: Artwork in Pharmathen User-Tested style: text edits
Version no: 9.4
Date of revision:
3 November 2015
As swatch(es)
Text 8pt Arial Narrow Headings 9pt Arial Narrow
Artwork software:
InDesign CS6
BAC ref:
S836 (formerly Q409)


Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.